title: Inactivation of SNF5 cooperates with p53 loss to accelerate tumor formation in Snf5(+/-);p53(+/-) mice.
abstract: Malignant rhabdoid tumors (MRTs) are poorly differentiated pediatric cancers that arise in various anatomical locations and have a very poor outcome. The large majority of these malignancies are caused by loss of function of the SNF5/INI1 component of the SWI/SNF chromatin remodeling complex. However, the mechanism of tumor development associated with SNF5 loss remains unclear. Multiple studies have demonstrated a role for SNF5 in the regulation of cyclin D1, p16(INK4A), and pRb(f) activities suggesting it functions through the SWI/SNF complex to affect transcription of genes involved in cell cycle control. Previous studies in genetically engineered mouse models (GEMM) have shown that loss of SNF5 on a p53-null background significantly accelerates tumor development. Here, we use established GEMM to further define the relationship between the SNF5 and p53 tumor suppressor pathways. Combined haploinsufficiency of p53 and Snf5 leads to decreased latency for MRTs arising in alternate anatomical locations but not for the standard facial MRTs. We also observed acceleration in the appearance of T-cell lymphomas in the p53(+/-);Snf5(+/-) mice. Our studies suggest that loss of SNF5 activity does not bestow a selective advantage on the p53 spectrum of tumors in the p53(+/-);Snf5(+/-) mice. However, reduced p53 expression specifically accelerated the growth of a subset of MRTs in these mice.
authors.affiliation: Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599-7295, USA.
authors.forename: Jessica
authors.initials: J
authors.lastname: DelBove
authors.forename: Yasumichi
authors.initials: Y
authors.lastname: Kuwahara
authors.forename: E Lorena
authors.initials: EL
authors.lastname: Mora-Blanco
authors.forename: Virginia
authors.initials: V
authors.lastname: Godfrey
authors.forename: William K
authors.initials: WK
authors.lastname: Funkhouser
authors.forename: Christopher D M
authors.initials: CD
authors.lastname: Fletcher
authors.forename: Terry
authors.initials: T
authors.lastname: Van Dyke
authors.forename: Charles W M
authors.initials: CW
authors.lastname: Roberts
authors.forename: Bernard E
authors.initials: BE
authors.lastname: Weissman
mesh_terms: D000818:Animals; D001859:Bone Neoplasms / Q000235:genetics / Q000473:pathology*; D018797:Cell Cycle Proteins / Q000378:metabolism; D002868:Chromosomal Proteins, Non-Histone / Q000502:physiology*; D005260:Female; D016399:Lymphoma, T-Cell / Q000235:genetics / Q000473:pathology*; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D012516:Osteosarcoma / Q000235:genetics / Q000473:pathology*; D018335:Rhabdoid Tumor / Q000235:genetics / Q000473:pathology*; D000071796:SMARCB1 Protein; D015996:Survival Rate; D016159:Tumor Suppressor Protein p53 / Q000502:physiology*
chemical_list: D018797:Cell Cycle Proteins; D002868:Chromosomal Proteins, Non-Histone; D000071796:SMARCB1 Protein; C513265:Smarcb1 protein, mouse; D016159:Tumor Suppressor Protein p53
references.citation: Lab Invest. 1984 Feb;50(2):232-8
references.pmid: 6198560
references.citation: J Med Genet. 2008 Jun;45(6):332-9
references.pmid: 18285426
references.citation: Nat Genet. 1993 Nov;5(3):225-9
references.pmid: 8275085
references.citation: Am J Hum Genet. 1999 Nov;65(5):1342-8
references.pmid: 10521299
references.citation: Mol Cell Biol. 2006 Apr;26(7):2661-74
references.pmid: 16537910
references.citation: Nature. 1998 Jul 9;394(6689):203-6
references.pmid: 9671307
references.citation: Hum Pathol. 1985 Dec;16(12):1235-42
references.pmid: 4065885
references.citation: Hum Pathol. 1981 Jul;12(7):646-57
references.pmid: 7275104
references.citation: Curr Biol. 1994 Jan 1;4(1):1-7
references.pmid: 7922305
references.citation: Nature. 2001 Sep 6;413(6851):86-91
references.pmid: 11544531
references.citation: J Cell Biol. 1998 Dec 14;143(6):1691-703
references.pmid: 9852160
references.citation: Cancer Res. 1999 Jan 1;59(1):74-9
references.pmid: 9892189
references.citation: Cancer Res. 2006 Aug 15;66(16):8076-82
references.pmid: 16912184
references.citation: Cancer Cell. 2002 Nov;2(5):415-25
references.pmid: 12450796
references.citation: Nature. 1992 Mar 19;356(6366):215-21
references.pmid: 1552940
references.citation: Cancer. 1978 May;41(5):1937-48
references.pmid: 206343
references.citation: Mol Cell Biol. 2001 May;21(10):3598-603
references.pmid: 11313485
references.citation: Mol Cell Biol. 2001 Sep;21(17):6017-30
references.pmid: 11486039
references.citation: Gen Diagn Pathol. 1996 May;141(5-6):327-37
references.pmid: 8780932
references.citation: Arch Pathol Lab Med. 1989 Feb;113(2):115-20
references.pmid: 2916902
references.citation: Mol Cell Biol. 2008 Oct;28(20):6223-33
references.pmid: 18710953
references.citation: Hum Mol Genet. 1999 Dec;8(13):2359-68
references.pmid: 10556283
references.citation: Mol Cell Biol. 1994 Apr;14(4):2686-98
references.pmid: 8139568
references.citation: J Cancer Res Clin Oncol. 2001;127(6):351-8
references.pmid: 11414195
references.citation: Cancer. 1982 Jun 1;49(11):2365-75
references.pmid: 7200394
references.citation: Genes Dev. 2005 Mar 15;19(6):665-70
references.pmid: 15769941
references.citation: Ann Diagn Pathol. 1998 Dec;2(6):351-62
references.pmid: 9930572
references.citation: Cancer Res. 2002 Jan 1;62(1):323-8
references.pmid: 11782395
references.citation: Diagn Mol Pathol. 1997 Dec;6(6):326-32
references.pmid: 9559292
references.citation: Cancer Chemother Pharmacol. 2002 Feb;49(2):142-8
references.pmid: 11862428
references.citation: Hum Mutat. 2008 Feb;29(2):227-31
references.pmid: 18072270
references.citation: Am J Hum Genet. 2007 Apr;80(4):805-10
references.pmid: 17357086
references.citation: Cancer Genet Cytogenet. 2005 Mar;157(2):127-33
references.pmid: 15721633
references.citation: Cancer Res. 1999 Jul 1;59(13):3152-6
references.pmid: 10397258
references.citation: Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13796-800
references.pmid: 11095756
references.citation: J Neurosci. 1996 Nov 1;16(21):6753-65
references.pmid: 8824316
references.citation: Cancer. 1983 Jul 15;52(2):290-6
references.pmid: 6861072
references.citation: Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17745-50
references.pmid: 16301525
references.citation: Cancer Sci. 2003 Dec;94(12):1059-65
references.pmid: 14662021
references.citation: Cancer Res. 2007 Apr 1;67(7):3002-9
references.pmid: 17409406
references.citation: EMBO Rep. 2000 Dec;1(6):500-6
references.pmid: 11263494
references.citation: Trends Cell Biol. 2008 May;18(5):244-52
references.pmid: 18406616